Back
NewLake Capital Partners Vs. Corbus Pharmaceuticals Holdings Industry Stock Comparison
Sell
49
NLCP
NewLake Capital Partners
Last Price:
19.40
Seasonality Move:
-11.71%
Buy
55
CRBP
Corbus Pharmaceuticals Holdings
Last Price:
37.54
Seasonality Move:
-15.12%
Sell
49
NewLake Capital Partners (NLCP)
is a Sell
Is NewLake Capital Partners a Buy, Sell or Hold?
- The current NewLake Capital Partners [NLCP] share price is $19.40. The Score for NLCP is 49, which is 2% below its historic median score of 50, and infers higher risk than normal.
- NLCP is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Buy
55
Corbus Pharmaceuticals Holdings (CRBP)
is a Buy
Is Corbus Pharmaceuticals Holdings a Buy, Sell or Hold?
- The current Corbus Pharmaceuticals Holdings [CRBP] share price is $37.25. The Score for CRBP is 55, which is 10% above its historic median score of 50, and infers lower risk than normal.
- CRBP is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
NLCP Stock Price Chart
What is NewLake Capital Partners's stock price today?
-
The NewLake Capital Partners share price today is $19.40
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and NLCP is experiencing slight buying pressure.
CRBP Stock Price Chart
What is Corbus Pharmaceuticals Holdings's stock price today?
-
The Corbus Pharmaceuticals Holdings share price today is $37.25
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and CRBP is experiencing slight selling pressure.
NLCP Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.31 | Buy |
| Relative Strength Index (14 RSI): | 68.25 | Buy |
| Chaikin Money Flow: | 23712 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (17.95 - 19.01) | Buy |
| Bollinger Bands (100): | (15.53 - 18.17) | Buy |
CRBP Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.25 | Sell |
| Relative Strength Index (14 RSI): | 50.46 | Buy |
| Chaikin Money Flow: | -42000 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (35.86 - 40.12) | Sell |
| Bollinger Bands (100): | (10.43 - 38.95) | Buy |
NLCP Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 18.72 | Buy |
| 20-day SMA: | 18.35 | Buy |
| 50-day SMA: | 17.7 | Buy |
| 200-day SMA: | 15.05 | Buy |
| 8-day EMA: | 18.78 | Buy |
| 20-day EMA: | 18.45 | Buy |
| 50-day EMA: | 17.82 | Buy |
| 200-day EMA: | 15.97 | Buy |
CRBP Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 36.09 | Buy |
| 20-day SMA: | 38.05 | Sell |
| 50-day SMA: | 37.07 | Buy |
| 200-day SMA: | 15.38 | Buy |
| 8-day EMA: | 36.54 | Buy |
| 20-day EMA: | 37.23 | Buy |
| 50-day EMA: | 34.53 | Buy |
| 200-day EMA: | 20.28 | Buy |
NewLake Capital Partners Earnings Growth & NLCP Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.05 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.09 per share, and a decrease next year of $0.00 per share.
Corbus Pharmaceuticals Holdings Earnings Growth & CRBP Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.69 per share, a decrease next quarter of $0.00 per share, an increase this year of $5.66 per share, and an increase next year of $0.09 per share.
NewLake Capital Partners Technical Analysis
| Apr 18 | Apr 19 | Apr 22 | Apr 23 | Apr 24 | Apr 25 | Apr 26 | Apr 29 | Apr 30 | May 1 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Apr | ||||||||||
| 18 | 19 | 22 | 23 | 24 | 25 | 26 | 29 | 30 | 01 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Corbus Pharmaceuticals Holdings Technical Analysis
| Apr 18 | Apr 19 | Apr 22 | Apr 23 | Apr 24 | Apr 25 | Apr 26 | Apr 29 | Apr 30 | May 1 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Apr | ||||||||||
| 18 | 19 | 22 | 23 | 24 | 25 | 26 | 29 | 30 | 01 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||